Personalized Cancer Medicine through Multiomics
- 1st Edition - October 1, 2026
- Latest edition
- Editors: Mohammad Azhar Aziz, Snober Shabnam Mir
- Language: English
Personalized Cancer Medicine through Multiomics explores the groundbreaking integration of multiomics to transform cancer diagnosis and treatment. This book delves into how the co… Read more
Data Mining & ML
Unlock the cutting edge
Up to 20% on trusted resources. Build expertise with data mining, ML methods.
Description
Description
Personalized Cancer Medicine through Multiomics explores the groundbreaking integration of multiomics to transform cancer diagnosis and treatment. This book delves into how the convergence of genomics, transcriptomics, proteomics, and metabolomics offers a comprehensive understanding of cancer biology, surpassing traditional single-omics approaches. The book details advancements in high-throughput technologies and computational methods, including machine learning, that enable the analysis of complex cancer datasets. It discusses how multiomics identifies unique molecular signatures, novel therapeutic targets, and biomarkers, facilitating precise and individualized treatment strategies, particularly for heterogeneous cancers. For academics, this book serves as an essential resource, compiling fragmented research into a single, coherent volume. It provides foundational knowledge, the latest advancements, and practical applications of multiomics in personalized medicine. Researchers will benefit from interdisciplinary approaches, real-world examples, and cutting-edge methodologies, making it an invaluable reference for advancing their work in oncology.
Key features
Key features
- Presents an in-depth exploration of genomics, transcriptomics, proteomics, and metabolomics, providing a holistic understanding of cancer biology that surpasses traditional single-omics approaches
- Details the latest advancements in high-throughput technologies and machine learning, enabling the analysis of complex cancer datasets
- Includes real-world case studies and practical insights, illustrating successful applications of multiomics in personalized medicine
Readership
Readership
Academic researchers and professionals in the fields of oncology, genomics, bioinformatics, and clinical medicine
Table of contents
Table of contents
1. Introduction about omics
2. Cancer Genomics
3. Cancer Transcriptomics
4. Cancer Proteomics
5. Cancer Metabolomics
6. Cancer lipidomics
7. Cancer and other omics
8. Cancer is a systems biology disease: Why multiomics is relevant for cancer?
9. Tools and techniques for integration of data from multiomics
10. Biomarker discovery through multiomics approach
11. Identification of therapeutic targets by employing multiomics
12. Multiomics for an individual patient: Relevance and possibilities
13. Personalized medicine: Fact or Fiction/ Hope or Hype?
14. Clinical translation of multiomics approach
15. Ethical aspects of personalized medicine
16. Economics of multiomics and personalized medicine
2. Cancer Genomics
3. Cancer Transcriptomics
4. Cancer Proteomics
5. Cancer Metabolomics
6. Cancer lipidomics
7. Cancer and other omics
8. Cancer is a systems biology disease: Why multiomics is relevant for cancer?
9. Tools and techniques for integration of data from multiomics
10. Biomarker discovery through multiomics approach
11. Identification of therapeutic targets by employing multiomics
12. Multiomics for an individual patient: Relevance and possibilities
13. Personalized medicine: Fact or Fiction/ Hope or Hype?
14. Clinical translation of multiomics approach
15. Ethical aspects of personalized medicine
16. Economics of multiomics and personalized medicine
Product details
Product details
- Edition: 1
- Latest edition
- Published: October 1, 2026
- Language: English
About the editors
About the editors
MA
Mohammad Azhar Aziz
Dr. Mohammad Azhar Aziz graduated from Jawaharlal Nehru university with PhD in Biotechnology. During PhD, he did pioneer work on anthrax vaccine development. He is a molecular biologist with domain expertise in Cancer biology. His interdisciplinary training enabled him to put together several disciplines and departments to address a scientific problem. He has successfully utilized nanoparticles to selectively target leukemia. He is an expert in Cancer Research with pioneer work on precision and personalized medicine in colorectal cancer with an integrative approach. He established 'Cancer Nanomedicine' Consortium at Aligarh Muslim University to bring together different departments for conducting cancer research and find translatable solutions for the patients.
Affiliations and expertise
Aligarh Muslim University, IndiaSM
Snober Shabnam Mir
Dr. Snober S. Mir is working as an Associate Professor in the Department of Biotechnology, Integral University, Lucknow. Her area of specialization is Molecular and Cell Biology, Cancer Biology and Yeast Biology. She obtained her Master’s degree in Biotechnology from IBU, Aligarh Muslim University and her Ph.D in Biotechnology from Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh. She has been a recipient of the Young Scientist Award by AACR-IACR during her doctoral studies and a research fellowship of PGIMER. Dr. Mir worked as a Postdoctoral Fellow at the Medical College of Georgia, USA and as Senior Research Associate on a European Commission funded project at CSIR-CDRI, Lucknow.She is also a recipient of DBT-BioCARE fellowship and a principal investigator on a DBT funded project. Her work has been published in several peer reviewed international journals
Affiliations and expertise
Integral University, Lucknow, India